Physician profile
Emiliya Melkumova
NPI 1962740472
$15,070.45
in general payments reported to CMS, 2019-2025
20 companies · $2,485 in 2025
The $2,485 reported for 2025 was more than what 82% of Vascular Neurology providers received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,001 · 2020: $259 · 2023: $376 · 2024: $11K · 2025: $2,485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $1,024 · Travel and Lodging: $962.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,825.00 |
| Food and Beverage | $1,024.44 |
| Travel and Lodging | $961.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $13,467.85 | 2023-2025 | |
| Sunovion Pharmaceuticals INC. | $509.64 | 2019-2020 | |
| Carestream Dental, LLC | $206.13 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $185.20 | 2019 | |
| Microtransponder, INC. | $136.98 | 2023 | |
| Allergan, INC. | $101.46 | 2019-2020 | |
| Csl Behring | $85.14 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $61.60 | 2019 | |
| Amgen INC. | $52.78 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $43.03 | 2019 | |
| Amneal Pharmaceuticals LLC | $39.44 | 2019 | |
| Ucb, INC. | $32.45 | 2020 | |
| Chiesi USA, INC. | $25.55 | 2019 | |
| Grifols USA, LLC | $21.67 | 2020 | |
| Boston Scientific Corporation | $20.73 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $20.00 | 2019 | |
| Ge Healthcare | $19.26 | 2019 | |
| Emd Serono, INC. | $17.16 | 2020 | |
| Acorda Therapeutics, INC | $12.58 | 2019 | |
| Novocure INC. | $11.80 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emiliya Melkumova listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.